Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-27

Clinical Trial Update: IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating IL-1RA treatment for pain and effusions in acute ACL tears was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cale Jacobs, PhD | Conditions: Anterior Cruciate Ligament Tear | Phase 2 | Status: TERMINATED | Results posted: 2021-10-27